Aralast NP

BIOLOGICAL2 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID), Shire

Conditions

Alpha1-antitrypsin DeficiencyChronic Obstructive Pulmonary DiseaseDiabetes Mellitus, Type 1

Phase 2

A Research Trial of Aralast NP in New Onset Diabetes (RETAIN) - Part II

WithdrawnNCT01183455

National Institute of Allergy and Infectious Diseases (NIAID)Diabetes Mellitus, Type 1

Start: 2010-10-31End: 2014-08-31Updated: 2014-12-31

Phase 4

ARALAST NP Alpha-1 Lung Density Chronic Obstructive Pulmonary Disease-Emphysema (COPD-E) Study

WithdrawnNCT04440488

ShireAlpha1-antitrypsin Deficiency, Chronic Obstructive Pulmonary Disease

Start: 2021-03-08End: 2025-09-12Updated: 2020-09-14